Luteolin Attenuates Dexamethasone-Induced Skeletal Muscle Atrophy in Male Albino Rats | ||
| The Medical Journal of Cairo University | ||
| Article 78, Volume 87, September, September 2019, Pages 3365-3374 PDF (1.01 M) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/mjcu.2019.65632 | ||
| Authors | ||
| NADIA HAWILA, M.Sc.; SABEHA HEDYA, M.D.; MAALY ABD ELMAABOUD, M.D.; AMANY ABDIN, M.D. | ||
| The Department of Pharmacology, Faculty of Medicine, Tanta University, Egypt | ||
| Abstract | ||
| Abstract Background: Glucocorticoid-induced skeletal muscle atrophy is the most common type of drug-induced myopathy. Aim of Study: This study was designated to investigate the effect of luteolin (Lut) on dexamethasone (Dex)-induced skeletal muscle atrophy in rats and the possible mechanisms of this effect. Material and Methods: Forty male Wistar rats divided into; control group, Dex group, and 3 other groups that were treated by Lut 25mg, 50mg and 100mg/kg/day; respectively for 14 days concomitantly with Dex. Body mass and muscle strength were recorded. Serum creatine kinase (CK) activity was assessed. Gastrocnemius muscle was weighed and proc-essed for assay of tissue reduced glutathione (GSH), malond-ialdehyde (MDA) levels. Histopathological and immunohis-tochemical studies were carried out. Results: Lut dose-dependently increased GSH, and cross-sectional area (CSA), and decreased MDA and caspases-3 immunoreactivity. Lut in a dose 50mg/kg/day improved the muscle mass and strength. Conclusion: This study demonstrates that luteolin is a protective agent against glucocorticoid-induced atrophy through antioxidant and anti-apoptotic properties. | ||
| Keywords | ||
| dexamethasone; Muscle atrophy; Luteolin | ||
|
Statistics Article View: 879 PDF Download: 1,026 |
||
